Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model
出版年份 2016 全文链接
标题
Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model
作者
关键词
Antibiotics, Acinetobacter baumannii, Synergy testing, Death rates, Acinetobacter infections, Pneumonia, Drug therapy, Gram negative bacteria
出版物
PLoS One
Volume 11, Issue 6, Pages e0157757
出版商
Public Library of Science (PLoS)
发表日期
2016-06-18
DOI
10.1371/journal.pone.0157757
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
- (2015) Lynette M. Phee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia
- (2015) Aristine Cheng et al. CRITICAL CARE MEDICINE
- In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis
- (2015) Wentao Ni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection
- (2015) Haifei Yang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant Acinetobacter baumannii Sepsis
- (2014) Gokcen Dinc et al. CHEMOTHERAPY
- Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii
- (2014) Irene Galani et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Combination therapy for carbapenem-resistant Gram-negative bacteria
- (2014) M. Paul et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Tigecycline in Combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-Producing Enterobacteriaceae in a Murine Thigh Infection Model
- (2013) George Michail et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2013) Hee Ji Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Is there really no benefit to combination therapy with colistin?
- (2013) Jason M Pogue et al. Expert Review of Anti-Infective Therapy
- In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection
- (2013) Michael Hornsey et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase
- (2013) Agnès Lefort et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Therapeutic options forAcinetobacter baumanniiinfections: an update
- (2012) Jordi Vila et al. EXPERT OPINION ON PHARMACOTHERAPY
- Colistin: an update on the antibiotic of the 21st century
- (2012) Silpak Biswas et al. Expert Review of Anti-Infective Therapy
- Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii
- (2012) Esmeray Mutlu Yilmaz et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In VivoEfficacy of Glycopeptide-Colistin Combination Therapies in aGalleria mellonellaModel ofAcinetobacter baumanniiInfection
- (2011) M. Hornsey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii
- (2011) D. W. Wareham et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii
- (2010) M. E. Pachon-Ibanez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii
- (2010) N. C. Gordon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia
- (2010) Y.-C. Chuang et al. CLINICAL INFECTIOUS DISEASES
- Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi
- (2009) S. W. Barthold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options
- (2008) Lisa L. Maragakis et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model
- (2008) Joon Young Song et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model
- (2008) Y. Morinaga et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now